洛陽玻璃(600876.SH):超白光熱材料項目生產線點火投產
格隆匯5月28日丨洛陽玻璃(600876.SH)公佈,公司全資子公司中建材(濮陽)光電材料有限公司超白光熱材料項目生產線主體工程已全部完工,於2020年5月28日順利點火投產。
該項目是中國建材集團有限公司自主研發設計的擁有自主知識產權的超白光熱玻璃生產線,該生產線生產的超白光熱玻璃,是用於太陽能光熱發電的重要基礎材料。該項目的建成投產,能夠進一步豐富公司現有的產品結構,增強公司的核心競爭力和可持續發展能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.